QUOTED. 22 October. Robert Ford.
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
“With a vaccine, you might see a trend of a little bit of a decrease in PCR testing I think and maybe an increase in antibody testing, but I think the rapid testing is not going to go away like that." – Robert Ford, CEO, Abbott
Click here for a free trial of Medtech Insight